Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Begay-Müller, Valerie Dr. (2) Birchmeier, Walter Prof. Dr. (1) Falcke, Martin Prof. Dr. (8) Herrmann, Pia (1) Hinz, Michael Dr. (2) Janz, Martin Dr. (5) Kettenmann, Helmut Prof. Dr. (2) Leutz, Achim Prof. Dr. (9) Scheidereit, Claus Prof. Dr. (4) Stein, Ulrike Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (1) (-) Kowenz-Leutz, Elisabeth Dr. (2) (-) Mathas, Stephan Dr. (9) (-) Biologie maligner Lymphome (9) Signaltransduktion in Tumorzellen (3) (-) Zelldifferenzierung und Tumorigenese (2) 1999 (1) (-) 2002 (4) (-) 2003 (2) 2004 (4) 2005 (3) 2006 (4) 2007 (3) (-) 2008 (5) 2009 (3) 2010 (4) 2011 (7) 2012 (1) 2013 (2) 2014 (2) 2015 (5) 2016 (3) 2017 (5) 2018 (2) 2019 (3) 2020 (3) 2021 (1) 11 Ergebnisse: Active Filter: Kowenz-Leutz, Elisabeth Dr.Mathas, Stephan Dr.Biologie maligner LymphomeZelldifferenzierung und Tumorigenese200220032008 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Dezember 2008 in Leukemia Notch inhibition blocks multiple myeloma cell-induced osteoclast activation R. Schwarzer M. Kaiser O. Acikgoez U. Heider S. Mathas R. Preissner O. Sezer B. Doerken F. Jundt 15. Oktober 2008 in Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas 26. September 2008 in J Biol Chem G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta O. Pless E. Kowenz-Leutz M. Knoblich J. Lausen M. Beyerman M.J. Walsh A. Leutz 01. September 2008 in Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas 01. August 2008 in Leukemia Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma F. Jundt O. Acikgoez S.H. Kwon R. Schwarzer I. Anagnostopoulos B. Wiesner S. Mathas M. Hummel H. Stein H.M. Reichardt B. Doerken 01. August 2003 in Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken 07. Februar 2003 in J Biol Chem Phosphorylation-dependent down-regulation of c-Myb DNA binding is abrogated by a point mutation in the v-myb oncogene K.B. Andersson E. Kowenz-Leutz E.M. Brendeford A.H.H. Tygsett A. Leutz O.S. Gabrielsen 01. November 2002 in Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou 02. September 2002 in J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit 01. Mai 2002 in Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Dezember 2008 in Leukemia Notch inhibition blocks multiple myeloma cell-induced osteoclast activation R. Schwarzer M. Kaiser O. Acikgoez U. Heider S. Mathas R. Preissner O. Sezer B. Doerken F. Jundt
15. Oktober 2008 in Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas
26. September 2008 in J Biol Chem G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta O. Pless E. Kowenz-Leutz M. Knoblich J. Lausen M. Beyerman M.J. Walsh A. Leutz
01. September 2008 in Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas
01. August 2008 in Leukemia Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma F. Jundt O. Acikgoez S.H. Kwon R. Schwarzer I. Anagnostopoulos B. Wiesner S. Mathas M. Hummel H. Stein H.M. Reichardt B. Doerken
01. August 2003 in Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken
07. Februar 2003 in J Biol Chem Phosphorylation-dependent down-regulation of c-Myb DNA binding is abrogated by a point mutation in the v-myb oncogene K.B. Andersson E. Kowenz-Leutz E.M. Brendeford A.H.H. Tygsett A. Leutz O.S. Gabrielsen
01. November 2002 in Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou
02. September 2002 in J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit
01. Mai 2002 in Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken
